Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss. Unfortunately, shortages and high costs have made it difficult for

Today, the Obesity Action Coalition (OAC) and The Obesity Society (TOS) sent a letter to the U.S. Food & Drug Administration (FDA), along with more

Amy Schumer had some positive praise for Mounjaro after a not-so-great experience with Wegovy years prior. “Three years ago, I tried Wegovy,” Schumer, 43, said

***Want more information on visiting the lab!? Link to Newsletter & Workout Chart below!*** https://beacons.ai/instituteofhumananatomy —- In this video, Jonathan from the Institute of Human

Abstract Aim We aimed to investigate glycated haemoglobin (HbA1c) levels and healthcare resource utilization (HCRU; emergency department [ED] visits or hospitalization) before and after adoption

Students from the University of Ottawa have come up with a brilliant way to essentially make copies of pharmaceutical drugs using plants. Their creation is

Early adopters of GLP-1 drugs have now lost the weight and are beginning to transition off them. How can F&B support the shift?

(Note: Thank you for supporting businesses like the one presenting a sponsored message below and working with them through the links below which benefits Gateway

As bariatric surgery evolves to make the most of GLP-1 drugs, issues of when and how to use them for best results are a key

What You Should Know:  – Quantum Health, a provider of healthcare navigation and care coordination, has announced the expansion of its Premier Pharmacy platform to

Post Content

The GLP-1 class of drugs used to treat diabetes and obesity may have the potential to benefit huge swaths of the public, but ongoing employer

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), one of the most-prescribed classes of medications worldwide, are indicated for the treatment of diabetes or obesity. A 2024

We recently published a list of Was Jim Cramer Right About These 13 Stocks? In this article, we are going to take a look at

Healthcare is a defensive sector that is more resilient to economic downturns than most others. That’s one of several reasons it is home to solid

Top of the morning to you, and a fine one it is, despite the dreary gray skies hovering over the Pharmalot campus. We are doing

Eli Lilly has launched Mounjaro in India, a new once-weekly injectable drug for type 2 diabetes and weight management. Approved by CDSCO, it targets GIP

AFTER months of careful research, Jennifer Dootson started weight loss injections, hoping to end two decades of yo-yo dieting. A year on, her weight has

GLP-1 agonists remain out of reach for many due to high costs, leading some patients to turn to unsafe compounded versions sold online. How should

Buying a top dividend stock when it’s near its 52-week low can be an excellent move for long-term investors to consider. That’s because it gives

Eli Lilly (NYSE: LLY) has been around for almost 150 years, finding ways to innovate and grow. Today, it’s the most valuable healthcare company in

For cardiologist Haritha Alla, a typical day in her Los Angeles-area clinic is ruled by mundane data collection. Patients struggle to fill out intake forms

Addiction and obesity share deep neurological roots. Can new treatments like GLP-1 drugs and MEAI help break the cycle? Explore the latest science behind these

Image source: The Motley Fool. General Mills (NYSE: GIS)Q3 2025 Earnings CallMar 19, 2025, 9:00 a.m. ET Contents: Prepared Remarks Questions and Answers Call Participants

Up in Canada, students have developed an incredible new way to synthesize drugs on plants — and they’re using Ozempic as their test case. In

People who rely on compounded GLP-1 drugs say they might not be able to afford brand-name versions, which are often not covered by insurance. Iuliia

What You Should Know: – Helix, a leader in population genomics and precision health, is announcing a new comprehensive clinico-genomic virtual registry of autoimmune disease

A WOMAN has left ht internet stunned after losing 8 stone in just 9 months with Mounjaro. Jess, from the UK, says she is so

(MedPage Today) — A meta-analysis of 27 randomized clinical trials found very low incidence of suicide-related adverse events among patients with diabetes or obesity on

In this week’s edition of InnovationRx, we look at the policy uncertainty around vaccines, sex differences in GLP-1 drug side effects, the challenges of using

Among weight loss drugs, Ozempic has become a phenomenon. With as much as $17 billion in sales in 2024, it shows no signs of slowing

When I give presentations about JAMA Psychiatry, people often ask me what our “strategy” is and how we decide what papers to publish. I respond

This systematic review and meta-analysis evaluates the risk of suicidality and self-harm in randomized, placebo-controlled trials of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) in

Viking Therapeutics (NASDAQ: VKTX) is a promising growth stock with a strong GLP-1 drug candidate in VK2735, which may eventually rake in significant revenue from